Pharmaron Beijing Co Ltd (PHBBF)
1.93
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Pharmaron Beijing Total Assets (Quarterly): 3.058B for March 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | 3.058B |
| December 31, 2022 | 2.970B |
| September 30, 2022 | 2.765B |
| June 30, 2022 | 2.830B |
| June 30, 2022 | 2.830B |
| March 31, 2022 | 2.935B |
| December 31, 2021 | 2.885B |
| September 30, 2021 | 2.710B |
| June 30, 2021 | 2.635B |
| June 30, 2021 | 2.635B |
| March 31, 2021 | 1.939B |
| December 31, 2020 | 1.823B |
| September 30, 2020 | 1.536B |
| Date | Value |
|---|---|
| June 30, 2020 | 1.408B |
| June 30, 2020 | 1.408B |
| March 31, 2020 | 1.305B |
| December 31, 2019 | 1.420B |
| September 30, 2019 | 782.45M |
| June 30, 2019 | 776.43M |
| June 30, 2019 | 776.43M |
| March 31, 2019 | 766.19M |
| December 31, 2018 | 698.08M |
| September 30, 2018 | 651.04M |
| June 30, 2018 | 643.53M |
| June 30, 2018 | 643.53M |
| December 31, 2017 | 600.30M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.305B
Minimum
Mar 2020
3.058B
Maximum
Mar 2023
2.300B
Average
2.635B
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| Sino Biopharmaceutical Ltd | 9.177B |
| HUTCHMED (China) Ltd | 1.261B |
| Regencell Bioscience Holdings Ltd | 8.438M |
| Prenetics Global Ltd | 233.31M |
| Uni-Bio Science Group Ltd | 62.37M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.420B |
| Shareholders Equity (Quarterly) | 1.595B |